Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Preferred Stock Liabilities (2019 - 2025)

Historic Preferred Stock Liabilities for International Stem Cell (ISCO) over the last 10 years, with Q3 2025 value amounting to $4.3 million.

  • International Stem Cell's Preferred Stock Liabilities changed 0.0% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $4.3 million for FY2024, which is 0.0% changed from last year.
  • Per International Stem Cell's latest filing, its Preferred Stock Liabilities stood at $4.3 million for Q3 2025, which was down 0.0% from $4.3 million recorded in Q2 2025.
  • International Stem Cell's 5-year Preferred Stock Liabilities high stood at $4.3 million for Q1 2021, and its period low was $4.3 million during Q1 2021.
  • For the 5-year period, International Stem Cell's Preferred Stock Liabilities averaged around $4.3 million, with its median value being $4.3 million (2021).
  • Over the last 5 years, International Stem Cell's Preferred Stock Liabilities had its largest YoY gain of 0.0% in 2021, and its largest YoY loss of 0.0% in 2021.
  • Over the past 5 years, International Stem Cell's Preferred Stock Liabilities (Quarter) stood at $4.3 million in 2021, then changed by 0.0% to $4.3 million in 2022, then changed by 0.0% to $4.3 million in 2023, then changed by 0.0% to $4.3 million in 2024, then changed by 0.0% to $4.3 million in 2025.
  • Its Preferred Stock Liabilities was $4.3 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.3 million in Q1 2025.